Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours.
about
High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastomaHistology predicts a favorable outcome in young children with desmoplastic medulloblastoma: a report from the children's oncology group.New concepts in the treatment of brain tumors in very young children.
P2860
Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours.
@ast
Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours.
@en
type
label
Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours.
@ast
Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours.
@en
prefLabel
Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours.
@ast
Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours.
@en
P2093
P2860
P356
P1476
Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours.
@en
P2093
B Cappelli
C Milanaccio
R Ladenstein
S Dallorso
P2860
P2888
P356
10.1038/SJ.BMT.1704841
P407
P478
35 Suppl 1
P577
2005-03-01T00:00:00Z